'Weeding the garden' lets ALK+ lung cancer patients continue crizotinib
A University of Colorado Cancer Center study published today in the International Journal of Radiation Oncology Biology and Physics shows that patients taking crizotinib for ALK+ non-small cell lung cancer may safely and ...
Jan 28, 2014
0
0